Clinical Trials

A Phase 1/2 First-in-human Study of BMS-986288 Alone and in Combination with Nivolumab in Advanced Malignant Tumors


Study ID
Bristol-Myers Squibb CA043-001

NCT Number
(Click on the NCT number for more information about the trial)

Research Study Number
2019-0324

Principle Investigator
Dr. Martin Gutierrez

Phase
I/II

Sponsor
Bristol-Myers Squibb


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now